 "money, investment, private equity, PE, banks")
Affirma Capital, a newly formed, independent private equity firm to be managed by the team from Standard Chartered Private Equity, has agreed to invest in the Tirupati Group, a leading nutraceuticals-focussed contract research and manufacturing company in India. Affirma will invest $50 million to support the organic and inorganic growth initiatives of the company. Affirma Capital/Stanchart PE is one of the three PE firms that hold a stake in CCD.
Established in 2005, Tirupati Group has since grown to become a leading value added contract research and manufacturing company for nutraceutical supplements in India. Tirupati has developed capabilities to cater to
